BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38663471)

  • 1. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
    He X; Liu X; Zuo F; Shi H; Jing J
    Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
    Lococo F; Boldrini L; Diepriye CD; Evangelista J; Nero C; Flamini S; Minucci A; De Paolis E; Vita E; Cesario A; Annunziata S; Calcagni ML; Chiappetta M; Cancellieri A; Larici AR; Cicchetti G; Troost EGC; Ádány R; Farré N; Öztürk E; Van Doorne D; Leoncini F; Urbani A; Trisolini R; Bria E; Giordano A; Rindi G; Sala E; Tortora G; Valentini V; Boccia S; Margaritora S; Scambia G
    BMC Cancer; 2023 Jun; 23(1):540. PubMed ID: 37312079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Multi-Omics Data With EHR for Precision Medicine Using Advanced Artificial Intelligence.
    Tong L; Shi W; Isgut M; Zhong Y; Lais P; Gloster L; Sun J; Swain A; Giuste F; Wang MD
    IEEE Rev Biomed Eng; 2024; 17():80-97. PubMed ID: 37824325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective.
    Hoseini SH; Enayati P; Nazari M; Babakhanzadeh E; Rastgoo M; Sohrabi NB
    J Gastrointest Cancer; 2024 Jun; 55(2):497-510. PubMed ID: 38168859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
    Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
    Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer.
    Zafari N; Bathaei P; Velayati M; Khojasteh-Leylakoohi F; Khazaei M; Fiuji H; Nassiri M; Hassanian SM; Ferns GA; Nazari E; Avan A
    Comput Biol Med; 2023 Mar; 155():106639. PubMed ID: 36805214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics, artificial intelligence, and precision medicine in perinatology.
    Pammi M; Aghaeepour N; Neu J
    Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of artificial intelligence multiomics in precision oncology.
    Srivastava R
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):503-510. PubMed ID: 35796775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
    Zhang S; Fan W; He D
    J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prognosis of Colorectal Cancer.
    Qiu H; Ding S; Liu J; Wang L; Wang X
    Curr Oncol; 2022 Mar; 29(3):1773-1795. PubMed ID: 35323346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases.
    Kiessling P; Kuppe C
    Genome Med; 2024 Jan; 16(1):14. PubMed ID: 38238823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards personalized medicine of colorectal cancer.
    Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
    Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A journey from omics to clinicomics in solid cancers: Success stories and challenges.
    Mehrotra S; Sharma S; Pandey RK
    Adv Protein Chem Struct Biol; 2024; 139():89-139. PubMed ID: 38448145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine.
    Lai B; Fu J; Zhang Q; Deng N; Jiang Q; Peng J
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration.
    Wei L; Niraula D; Gates EDH; Fu J; Luo Y; Nyflot MJ; Bowen SR; El Naqa IM; Cui S
    Br J Radiol; 2023 Oct; 96(1150):20230211. PubMed ID: 37660402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
    Ahmed Z
    Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.